Specific antagonist of retinoid toxicity in mice

Toxicology and Applied Pharmacology

Volumn 138, Issue 1, 1996, Pages 169-175

  Standeven, Andrew M ^a   Johnson, Alan T ^a   Escobar, Maria ^a   Chandraratna, Roshantha A S ^a  

^a ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; 4 [2 [5,6 DIHYDRO 5,5 DIMETHYL 8 (4 METHYLPHENYL) 2 NAPHTHYL]ETHYNYL]BENZOIC ACID; RETINOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INTOXICATION; FEMALE; INTRAGASTRIC DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SKIN TOXICITY; TOPICAL DRUG ADMINISTRATION; WEIGHT REDUCTION;

ANIMALIA;

EID: 0029891967     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0110     Document Type: Article

References (35)

1. Apfel, C., Bauer, F., Crettaz, M., Forni, L., Kamber, M., Kaufmann, F., LeMotte, P., Pirson, W., and Klaus, M. (1992). A retinoic-acid-receptor-alpha antagonist selectively counteracts retinoic acid effects. Proc. Natl. Acad. Sci. USA 89, 7129-7133.
2. Armstrong, R. B., Ashenfelter, K. O., Eckhoff, C., Levin, A. A., and Shapiro, S. S. (1994). General and reproductive toxicology of retinoids. In The Retinoids: Biology, Chemistry, and Medicine (M. B. Sporn, A. B. Roberts, and D. S. Goodman, Eds.), pp. 545-572. Raven Press, New York.
3. Beehler, B. C., Chen, S., and Tramposch, K. M. (1995). Gene expression of retinoic acid receptors and cellular retinoic acid-binding proteins in rhino and hairless mouse skin. Arch. Dermatol. Res. 287, 488-493.
4. Chen, S., Ostrowski, J., Whiting, G., Roalsvig, T., Hammer, L., Currier, S. J., Honeyman, J., Kwasniewski, B., Yu, K.-L., Sterzycki, R., Kim, C. U., Starrett, J., Mansuri, M., and Reczek, P. R. (1995). Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models. J. Invest. Dermatol. 104, 779-783.
5. Clark, L. (1971). Hypervitaminosis A: A review. Aust. Vet. J. 47, 568-571.
6. Draize, J. H., Woodard, G., and Calvery, H. O. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 82, 377-390.
7. Eckhardt, K., and Schmitt, G. (1994). A retinoic acid receptor a antagonist counteracts retinoid teratogenicity in vitro and reduces incidence and/or severity of malformations in vivo. Toxicol. Lett. 70, 299-308.
8. Edwards, L., and Jaffe, P. (1990). The effect of topical tretinoin on dysplastic nevi. Arch. Dermatol. 126, 494-499.
9. Elias, P. M. (1987). Retinoid effects on the epidermis. Dermatologica 175(Suppl. 1), 28-36.
10. Elias, P. M., Fritsch, P. O., Lampe, M., Williams, M. L., Brown, B. E., Nemanic, M., and Grayson, S. (1981). Retinoid effects on epidermal structure, differentiation, and permeability. Lab. Invest. 44, 531-540.
11. Esgleyes-Ribot, T., Chandraratna, R. A., Lew-Kaya, D. A., Sefton, J., and Duvic, M. (1994). Response of psoriasis to a new topical retinoid, AGN 190168. J. Am. Acad. Dermatol. 30, 581-590.
12. Eyrolles, L., Kagechika, H., Kawachi, E., Fukasawa, H., Iijima, T., Matsushima, Y., Hashimoto, Y., and Shudo, K. (1994). Retinobenzoic acids. 6. Retinoid antagonists with a heterocyclic ring. J. Med. Chem. 37, 1508-1517.
13. Graf, N., Riesinger, P., and Reinhard, H. (1995). Retinoids in the treatment of acute promyelocytic leukemia: Review of the literature. Klin. Padiatr. 207, 43-47.
14. Griffiths, C. E. M., Finkel, L. J., Tranfaglia, M. G., Hamilton, T. A., and Voorhees, J. J. (1993). An in vivo experimental model for effects of topical retinoic acid in human skin. Br. J. Dermatol. 129, 389-394.
15. Griffiths, C. E. M., and Voorhees, J. J. (1993). Topical retinoic acid for photoaging: Clinical response and underlying mechanisms. Skin. Pharmacol. 6(Suppl. 1), 70-77.
16. Hoting, E., and Meissner, K. (1988). Arotinoid-ethylester: Effectiveness in refractory cutaneous T-cell lymphoma. Cancer 62, 1044-1048.
17. Johnson, A. T., Klein, E., Gillett, S. J., Wang, L., Song, T. K., Pino, M., and Chandraratna, R. A. S. (1995). Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem, 38, 4764-4767.
18. Kligman, L. H., and Kligman, A. M. (1981). Histogenesis and progression of ultraviolet light-induced tumors in hairless mice. J. Natl. Cancer Inst. 67, 1289-1297.
19. Kopper, S., Castilleja, O., Arefieg, T., Chandraratna, R., and Thacher, S. (1994). Retinoid analysis by transepidermal water loss in micropigs. FASEB J. 8, A347.
20. Kovacs, J. A. J., and Shear, N. H. (1993). Adverse nonreproductive effects of retinoids in humans. In Retinoids in Clinical Practice: The Risk-Benefit Ratio (G. Koren, Ed.), pp. 241-260. Dekker, New York.
21. Lewin, A. H., Bos, M. E., Zusi, F. C., Nair, X., Whiting, G., Bouquin, P., Tetrault, G., and Carroll, F. I. (1994). Evaluation of retinoids as therapeutic agents in dermatology. Pharm. Res. 11, 192-200.
22. Lindamood, C., III, Cope, F. O., Dillehay, D. L., Everson, M. P., Giles, H. D., Lamon, E. W., McCarthy, D. J., Sartin, J. L., and Hill, D. L. (1990). Pharmacological and toxicological properties of arotinoids SMR-2 and SMR-6 in mice. Fundam. Appl. Toxicol. 14, 15-29.
23. Lindamood, C., III, Giles, H. D., and Hill, D. L. (1987). Preliminary toxicity profile of arotinoids SMR-2 and SMR-6 in male B6D2F1 mice. Fundam. Appl. Toxicol. 8, 517-530.
24. Lindemayr, H. (1986). Isotretinoin intoxication in attempted suicide. Acta. Derm. Venereol. 66, 452-453.
25. Loeliger, P., Bollag, W., and Mayer, H. (1980). Arotinoids, a new class of highly active retinoids. Eur. J. Med. Chem. Chim. Ther. 15, 9-15.
26. Look, J., Landwehr, J., Bauer, F., Hoffmann, A. S., Bluethmann, H., and Lemotte, P. (1995). Marked resistance of RARγ-deficient mice to the toxic effects of retinoic acid. Am. J. Physiol. 269, 91-98.
27. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. (1994). The retinoid receptors. In The Retinoids: Biology, Chemistry, and Medicine (M. B. Sporn, A. B. Roberts, and D. S. Goodman, Eds.), pp. 319-349. Raven Press, New York.
28. Miller, W. H., Jakubowski, A., Tong, W. P., Miller, V. A., Rigas, J. R., Benedetti, F., Gill, G. M., Truglia, J. A., Ulm, E., Shirley, M., and Warrell, R. P., Jr. (1995). 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 85, 3021-3027.
29. Pignatello, M. A., Kauffman, F. C., and Levin, A. A. (1995). Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (RO 13-7410). Toxicologist 15, 159.
30. Silverman, A. K., Ellis, C. N., and Voorhees, J. J. (1987). Hypervitaminosis A syndrome: A paradigm of retinoid side effects. J. Am. Acad. Dermatol. 16, 1027-1039.
31. Teelmann, K. (1990). Testing of retinoids for systemic and topical use in human psoriasis and other disorders of keratinization: Mouse papilloma test. Methods Enzymol. 190, 382-395.
32. Turton, J. A., Hicks, R. M., Gwynne, J., Hunt, R., and Hawkey, C. M. (1985). Retinoid toxicity. Ciba Found. Symp. 113, 220-251.
33. Valcarcel, R., Holz, H., Garcia Jimenez, C., Barettino, D., and Stunnenberg, H. G. (1994). Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer. Genes Dev. 8, 3068-3079.
34. Verschoore, M., Bouclier, M., Czernielewski, J., and Hensby, C. (1993). Topical retinoids: Their uses in dermatology. Dermatol. Clin. 11, 107-115.
35. Yoshimura, H., Nagai, M., Hibi, S., Kikuchi, K., Abe, S., Hida, T., Higashi, S., Hishinuma, I., and Yamanaka, T. (1995). A novel type of retinoic acid receptor antagonist: Synthesis and structure-activity relationships of heterocyclic ring-containing benzoic acid derivatives. J. Med. Chem. 38, 3163-3173.